AMG 691

DRUG2 trials

Sponsors

Amgen

Conditions

AsthmaHealthy Participants

Phase 1

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

Active, not recruitingNCT06637371

Start: 2024-10-16End: 2027-04-10Updated: 2026-06-17

A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers

RecruitingNCT07745907

AmgenHealthy Participants

Start: 2026-08-07End: 2027-03-31Target: 28Updated: 2026-08-27